Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Gilbert

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1988
OKT3 monoclonal antibody in heart transplantationM R Bristow, E M Gilbert, J B O'Connell, et al.
Circulation|March 1, 1990
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heartJ D Port, E M Gilbert, P Larrabee, et al.
The American Journal of Cardiology|October 1, 1996
Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathyR A Quaife, E M Gilbert, P E Christian, et al.
Journal of the American College of Cardiology|May 1, 1991
Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathyJ L Anderson, E M Gilbert, J B O'Connell, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 1, 1996
Exercise capacity after heart transplantation: influence of donor and recipient characteristicsD G Renlund, D O Taylor, R D Ensley, et al.
Journal of Cardiac Failure|September 21, 2000
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant PhysiciansJ A Franciosa, W T Abraham, M Fowler, et al.
Journal of the American College of Cardiology|May 15, 1998
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failureS F Shakar, W T Abraham, E M Gilbert, et al.
Circulation|January 1, 1991
Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study GroupR W Henthorn, A L Waldo, J L Anderson, et al.
Circulation|December 1, 1989
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study GroupJ L Anderson, E M Gilbert, B L Alpert, et al.
The American Journal of Cardiology|December 15, 1995
Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathyM White, F Yanowitz, E M Gilbert, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1988
OKT3 monoclonal antibody in heart transplantationM R Bristow, E M Gilbert, J B O'Connell, et al.
Circulation|March 1, 1990
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heartJ D Port, E M Gilbert, P Larrabee, et al.
The American Journal of Cardiology|October 1, 1996
Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathyR A Quaife, E M Gilbert, P E Christian, et al.
Journal of the American College of Cardiology|May 1, 1991
Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathyJ L Anderson, E M Gilbert, J B O'Connell, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 1, 1996
Exercise capacity after heart transplantation: influence of donor and recipient characteristicsD G Renlund, D O Taylor, R D Ensley, et al.
Journal of Cardiac Failure|September 21, 2000
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant PhysiciansJ A Franciosa, W T Abraham, M Fowler, et al.
Journal of the American College of Cardiology|May 15, 1998
Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failureS F Shakar, W T Abraham, E M Gilbert, et al.
Circulation|January 1, 1991
Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia. The Flecainide Supraventricular Tachycardia Study GroupR W Henthorn, A L Waldo, J L Anderson, et al.
Circulation|December 1, 1989
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study GroupJ L Anderson, E M Gilbert, B L Alpert, et al.
The American Journal of Cardiology|December 15, 1995
Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathyM White, F Yanowitz, E M Gilbert, et al.
Pageof 9